GR930300100T1 - - Google Patents

Info

Publication number
GR930300100T1
GR930300100T1 GR930300100T GR930300100T GR930300100T1 GR 930300100 T1 GR930300100 T1 GR 930300100T1 GR 930300100 T GR930300100 T GR 930300100T GR 930300100 T GR930300100 T GR 930300100T GR 930300100 T1 GR930300100 T1 GR 930300100T1
Authority
GR
Greece
Prior art keywords
tested
solution
substance
determined
methacin
Prior art date
Application number
GR930300100T
Other languages
Greek (el)
English (en)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of GR930300100T1 publication Critical patent/GR930300100T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GR930300100T 1991-10-26 1993-10-29 GR930300100T1 (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances

Publications (1)

Publication Number Publication Date
GR930300100T1 true GR930300100T1 (enEXAMPLES) 1993-10-29

Family

ID=8207282

Family Applications (3)

Application Number Title Priority Date Filing Date
GR930300100T GR930300100T1 (enEXAMPLES) 1991-10-26 1993-10-29
GR940300077T GR940300077T1 (en) 1991-10-26 1994-11-30 Method and composition for determining the immunological activity of bioactive substances.
GR970402095T GR3024457T3 (en) 1991-10-26 1997-08-14 Method and composition for determining the immunological activity of bioactive substances.

Family Applications After (2)

Application Number Title Priority Date Filing Date
GR940300077T GR940300077T1 (en) 1991-10-26 1994-11-30 Method and composition for determining the immunological activity of bioactive substances.
GR970402095T GR3024457T3 (en) 1991-10-26 1997-08-14 Method and composition for determining the immunological activity of bioactive substances.

Country Status (22)

Country Link
US (1) US5543300A (enEXAMPLES)
EP (2) EP0539610A1 (enEXAMPLES)
JP (1) JPH07500905A (enEXAMPLES)
AT (1) ATE153763T1 (enEXAMPLES)
AU (1) AU678343B2 (enEXAMPLES)
BG (1) BG61705B1 (enEXAMPLES)
CA (1) CA2122131A1 (enEXAMPLES)
CZ (1) CZ100494A3 (enEXAMPLES)
DE (3) DE539610T1 (enEXAMPLES)
DK (1) DK0609255T3 (enEXAMPLES)
ES (1) ES2061424T3 (enEXAMPLES)
FI (1) FI941920L (enEXAMPLES)
GR (3) GR930300100T1 (enEXAMPLES)
HU (1) HU216863B (enEXAMPLES)
LV (1) LV12140B (enEXAMPLES)
NO (1) NO941444L (enEXAMPLES)
PL (1) PL170592B1 (enEXAMPLES)
RO (1) RO114837B1 (enEXAMPLES)
RU (1) RU2125727C1 (enEXAMPLES)
SG (1) SG72665A1 (enEXAMPLES)
SK (1) SK44094A3 (enEXAMPLES)
WO (1) WO1993008470A1 (enEXAMPLES)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016786A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Oxihumic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
US7497947B2 (en) 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
AU1360492A (en) * 1991-03-16 1992-10-21 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
DK0609255T3 (da) 1997-12-22
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
DE69220078T2 (de) 1997-12-04
US5543300A (en) 1996-08-06
NO941444D0 (no) 1994-04-21
DE539610T1 (de) 1993-12-16
HK1002610A1 (en) 1998-09-04
WO1993008470A1 (en) 1993-04-29
GR3024457T3 (en) 1997-11-28
ATE153763T1 (de) 1997-06-15
EP0609255A1 (en) 1994-08-10
PL170592B1 (en) 1997-01-31
SK44094A3 (en) 1995-03-08
GR940300077T1 (en) 1994-11-30
FI941920A7 (fi) 1994-04-25
FI941920A0 (fi) 1994-04-25
LV12140B (lv) 1998-12-20
HU9401185D0 (en) 1994-07-28
AU2650992A (en) 1993-05-21
ES2061424T1 (es) 1994-12-16
HU216863B (hu) 1999-09-28
CZ100494A3 (en) 1994-11-16
BG61705B1 (bg) 1998-03-31
SG72665A1 (en) 2000-05-23
CA2122131A1 (en) 1993-04-29
DE69220078D1 (de) 1997-07-03
RU94022481A (ru) 1996-09-27
NO941444L (no) 1994-06-16
JPH07500905A (ja) 1995-01-26
ES2061424T3 (es) 1997-10-01
RU2125727C1 (ru) 1999-01-27
EP0539610A1 (en) 1993-05-05
FI941920L (fi) 1994-04-25
RO114837B1 (ro) 1999-07-30
LV12140A (lv) 1998-09-20
HUT69990A (en) 1995-09-28
EP0609255B1 (en) 1997-05-28
BG98720A (bg) 1995-07-28

Similar Documents

Publication Publication Date Title
US4632980B1 (enEXAMPLES)
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
EG18436A (en) Therapeutical application of phosponylmethoxy-alkyl adenines
GR930300100T1 (enEXAMPLES)
EP0376251A3 (en) An anticoagulant substance obtained from urine
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
EP0094317A3 (en) Production of interleukin and its analogous immune regulating factors
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
ATE139984T1 (de) Wasserreinigungssystem
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
FI891210A7 (fi) Tiosulfiinihappojohdannaiset, niiden käyttö tulehdussairauksien käsitt elyyn sekä näitä aineita sisältävät lääkeaineet
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DK183788D0 (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
DE3861273D1 (de) Taurinderivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.
FR2627487B1 (fr) Nouveau derive de l'acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant
CU22041A1 (es) Procedimiento para la obtencion de factor de transferencia leucocitario.